Neuroone Medical Technologies

Yahoo Finance • 25 days ago

Upcoming Dividend Run For GILD?

This morning a "Potential Dividend Run Alert" went out for Gilead Sciences Inc (NASD: GILD), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situation in greater detail, shall we? First... Full story

Yahoo Finance • last month

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMT... Full story

Yahoo Finance • last month

NeuroOne Q3 Revenue Jumps 105 Percent

NeuroOne Medical Technologies(NASDAQ:NMTC) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising to 53.9% from 34.1% in the third quarte... Full story

Yahoo Finance • last month

NeuroOne raises product gross margin outlook to 53% as management highlights new pain management initiatives

Earnings Call Insights: NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 MANAGEMENT VIEW * CEO David A. Rosa reported "excellent progress in the third quarter of fiscal year 2025 on our financial objectives as well as achieving... Full story

Yahoo Finance • last month

NeuroOne Medical Technologies (NASDAQ:NMTC) Reports Mixed Q3 2025 Earnings with Strong EPS Beat and 7% Pre-Market Surge

NeuroOne Medical Technologies Corp (NASDAQ:NMTC [https://www.chartmill.com/stock/quote/NMTC/profile]) reported its third-quarter fiscal 2025 earnings, delivering mixed results relative to analyst expectations. While revenue growth was stro... Full story

Yahoo Finance • last month

Earnings call transcript: NeuroOne Medical Q3 2025 beats revenue expectations

NeuroOne Medical Technologies Corp (NMTC) reported its Q3 2025 earnings, surpassing revenue forecasts with a 9.68% surprise. The company posted a $1.7 million revenue, exceeding the expected $1.55 million. Earnings per share (EPS) improved... Full story

Yahoo Finance • last month

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”),... Full story

Yahoo Finance • 2 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • 2 months ago

NeuroOne receives allowance for key patent from U.S. Patent & Trademark Office

* NeuroOne Medical Technologies (NASDAQ:NMTC [https://seekingalpha.com/symbol/NMTC]) said on Wednesday that it has received a notice of allowance [https://seekingalpha.com/pr/20174982-neuroone-receives-notice-of-allowance-for-key-patent-... Full story

Yahoo Finance • 2 months ago

NeuroOne receives patent allowance for neural probe technology

EDEN PRAIRIE, Minn. - NeuroOne Medical Technologies Corporation (NASDAQ:NMTC), whose stock has surged over 42% in the past week, has received a notice of allowance from the U.S. Patent and Trademark Office for a patent titled "Methods for... Full story

Yahoo Finance • 2 months ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a me... Full story

Yahoo Finance • 4 months ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • 4 months ago

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien... Full story

Yahoo Finance • 4 months ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

Filed 510(k)Submission with FDA for OneRF®Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2 Million Capital Raise EDEN PRAIRIE, Mi... Full story

Yahoo Finance • 5 months ago

NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ...

Release Date: January 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points NeuroOne Medical Technologies Corp (NASDAQ:NMTC) has three FDA 510(k) cleared electrode... Full story

Yahoo Finance • 6 months ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering... Full story

Yahoo Finance • 6 months ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering... Full story

Yahoo Finance • 6 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for pati... Full story

Yahoo Finance • 6 months ago

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) --  Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessica Clark, DNP, RN, Dean of the College... Full story

Yahoo Finance • 7 months ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for pati... Full story